CBD businesses cheered the DEA’s rescheduling of some CBD as a signal that opposition to cannabis is starting to crumble. This post from Marijuana Business Daily discusses the limited expansion of cannabis access. The U.S. Drug Enforcement Administration has taken some cannabidiol out of the most restrictive class of controlled substances, a move that allows the sale of the ... Continue Reading
DEA
Marijuana Research: Are Domestic Suppliers Being Ignored?
A bipartisan group of U.S. representatives is seeking answers about why the federal government is seemingly favoring foreign marijuana suppliers while stalling the approval of additional domestic cannabis producers. In a letter addressed to the acting administrator of the Drug Enforcement Administration (DEA) and U.S. Attorney General Jeff Sessions, 15 members of Congress, ... Continue Reading
What the FDA Recommends About CBD Scheduling
FDA considered 8 factors to make its CBD scheduling recommendation, concluding that CBD doesn’t meet the criteria for federal control at all. This post from Marijuana Moment sheds more light on FDA's suggestions. Last week’s decision by the U.S. Drug Enforcement Administration (DEA) to place a marijuana-derived drug in the least restrictive category under federal law was ... Continue Reading
DEA May Allow 450% More Cannabis for Research in 2019
The federal quota for cannabis production used in medical research will be over 450% higher in 2019. DEA just changed its tune on marijuana again. This post from The Motley Fool analyzes DEA's stance in more detail. Big changes are under way right now in our neighbor to the north. Beginning Oct. 17, recreational marijuana will officially go on sale in Canada, making it the ... Continue Reading
Senate Panel Criticizes Cannabis’ Schedule 1 Barrier
A key U.S. Senate committee says that cannabis' current federal classification of schedule 1 blocks scientific research on its effects. But despite the seeming concern about the effect of state legalization, the panel's criticism of Schedule I's roadblocks to marijuana research provides more momentum to the effort to reclassify cannabis under federal law. This post from Forbes, ... Continue Reading